Fortis Healthcare update on subsidiaries

Update on sale of stake held by Fortis Cancer Care in Lalitha Healthcare

Fortis Healthcare announced that Fortis Cancer Care ('FCCL'), a step down subsidiary of the Company had entered into a memorandum of understanding with Lalitha Healthcare ('LHPL'), another step down subsidiary of the Company, Dr. Lakshmi Narayana Raju, Lakshmi Priya, S. Venkataramana Raju (collectively the 'Promoters of LHPL') and Anikrish Hospitals, for, inter alia, sale of the entire shareholding held by FCCL, representing 79.43% of the total issued and paid up equity share capital of LHPL, to the Promoters of LHPL ('Proposed Transaction').

Further, the Parties to the MOU had on 22 February 2018 agreed, to extend the Long Stop Date with effect from 17 February 2018 for 6 (Six) Months i.e. till 16 August 2018.

Powered by Capital Market - Live News


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel